G-CREDIT (Gangnam-Cohort for Risk Evaluation of Diabetes and Impaired Glucose Tolerance)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Type 2 Diabetes
- Sponsor
- Yonsei University
- Enrollment
- 500
- Primary Endpoint
- Sleep, exercise, daily activity check
- Status
- Not yet recruiting
- Last Updated
- 10 years ago
Overview
Brief Summary
The prevalence of type 2 diabetes has consistently increased and type 2 diabetes can cause many types of vascular complications. Diabetes develops due to glucose intolerance. Early detection and intervention in the stage of glucose intolerance makes it afford to prevent overt diabetes and its complications. This study was designed to make a cohort of korean patients with glucose intolerance to construct a long term database about clinical characteristics of these patients.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients older than 20 years old who has visited Gangnam severance hospital since January
- •Patients with either diabetes or impaired glucose tolerance
- •Patients with at least 6 months of follow-up period
Exclusion Criteria
- •Patients with gestational diabetes, any active stage of cancer and severe disability
Outcomes
Primary Outcomes
Sleep, exercise, daily activity check
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Diet
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Fundus photography, fat computed tomography
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Smoking, alcohol history
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
SMA, TG, HDL, LDLM apoA, apoB
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Urine protein, albumin, creatinine
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
EKG, Neurometer, Chest PA, Abdominal sonography
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Life style assessment - Past medical history - Smoking, alcohol history - Sleep, exercise, daily activity check - Diet - Reproductive status (Women only) - Socioeconomic status
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Reproductive status (Women only)
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Socioeconomic status
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Anthropometric measurements : Height, weight, waist circumference, pulse rate, blood pressure
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
HOMA-IR, HOMA-β
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
Past medical history
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications
PC2hrs, HbA1C, Insulin, C-peptide (AC, PC2hr), hs-CRP
Time Frame: an expected average of 12 weeks
Measuring above all, investigators plan to investigate how clinical parameters help to predict and prevent diabetic vascular complications